Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
14.86
-0.67 (-4.31%)
Jul 11, 2025, 9:45 AM - Market open
Oscar Health Stock Forecast
Stock Price Forecast
The 6 analysts that cover Oscar Health stock have a consensus rating of "Sell" and an average price target of $15.58, which forecasts a 4.56% increase in the stock price over the next year. The lowest target is $10 and the highest is $23.
Price Target: $15.58 (+4.56%)
Analyst Consensus: Sell
Analyst Ratings
The average analyst rating for Oscar Health stock is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 4 | 3 | 3 | 3 | 1 | 1 |
Hold | 2 | 3 | 3 | 3 | 2 | 1 |
Sell | 2 | 2 | 2 | 2 | 2 | 4 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 8 | 8 | 8 | 5 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Hold → Sell Downgrades $16 → $10 | Hold → Sell | Downgrades | $16 → $10 | -32.71% | Jul 11, 2025 |
Barclays | Barclays | Sell Initiates $17 | Sell | Initiates | $17 | +14.40% | Jul 2, 2025 |
Piper Sandler | Piper Sandler | Buy Maintains $25 → $18 | Buy | Maintains | $25 → $18 | +21.13% | Jun 9, 2025 |
Wells Fargo | Wells Fargo | Buy → Hold Downgrades $20 → $16 | Buy → Hold | Downgrades | $20 → $16 | +7.67% | Mar 13, 2025 |
Jefferies | Jefferies | Sell Initiates $12 | Sell | Initiates | $12 | -19.25% | Dec 10, 2024 |
Financial Forecast
Revenue This Year
11.55B
from 9.18B
Increased by 25.81%
Revenue Next Year
11.62B
from 11.55B
Increased by 0.60%
EPS This Year
0.70
from 0.10
Increased by 603.80%
EPS Next Year
0.90
from 0.70
Increased by 28.36%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 12.5B | 13.3B | 14.9B |
Avg | 11.5B | 11.6B | 13.3B |
Low | 10.8B | 10.4B | 11.4B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 36.0% | 15.4% | 28.7% |
Avg | 25.8% | 0.6% | 14.8% |
Low | 18.0% | -9.8% | -2.0% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.92 | 1.97 | 2.36 |
Avg | 0.70 | 0.90 | 1.67 |
Low | 0.58 | 0.09 | 0.54 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 824.0% | 180.5% | 161.5% |
Avg | 603.8% | 28.4% | 85.2% |
Low | 478.2% | -87.5% | -40.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.